// App-Quantinova.ai

760 : Incomplete Complement Inhibition in Patients with PNH on Eculizumab - 5 Year Experience from the National PNH Service Leeds

Researchers

Presenter

  • Rachael Jones

Principal Investigators

  • Petra Muus

  • Alexandra Pike

  • Louise Arnold

  • Jeanifer Gachev

  • Briony Forrest

  • Peter Hillmen

  • Morag Griffin

Medical Centers

  • Department of Diabetes and Endocrinology, St James University Hospital, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Lactate dehydrogenase

  • Total complement hemolytic activity

Drug/Treatment

  • Eculizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved